_(7184104335).webp)
Why Failure-to-Market Claims Are Preempted Under Federal Law
This short white paper addresses preemption arguments relevant to “failure to market” claims, which cover those cases in which plaintiffs allege that drug companies may be held liable for failing to bring to market, as quickly as possible, drugs that present (allegedly) fewer side effects than other, FDA-approved drugs already on the market.
A California appellate court invented out of whole cloth a new and troubling theory of tort liability. Specifically, the court held that drug companies have a duty to develop and bring to market drugs that are supposedly safer and more effective than another, FDA-approved drug the company sells already. The claim rested on factual premises contradicted by all publicly available information, the acceptance of which could seriously disrupt the FDA approval process. This disruption gives rise to an issue the parties did not raise on appeal and that the appeals court never addressed, notwithstanding the complex, comprehensive statutes governing drug approval: these state tort law claims are preempted under theories of both field and conflict (including obstacle) preemption. This White Paper explains why it is imperative for the federal government and private parties to advance these preemption arguments, and why the courts should accept them.
Read the Issue Brief
This white paper was originally published by the Pacific Research Institute's Center for Medical Economics and Innovation.
Economic Dynamism

Automated Detection of Emotion in Central Bank Communication: A Warning
Can LLMs help us better understand the role of emotion in central bank communication?

Defending Technological Dynamism & the Freedom to Innovate in the Age of AI
Human flourishing, economic growth, and geopolitical resilience requires innovation—especially in artificial intelligence.

Firm Investment and the User Cost of Capital: New U.S. Corporate Tax Reform Evidence
This working paper analyzes the Tax Cuts and Jobs Act of 2017 to examine how corporate tax reform impacts rates of investment.

It’s Not Easy, but We Can All Learn to Think like Adam Smith
To truly understand what a dynamic economy requires, we would do well to recover the 18th-century sensibility that understood dynamism as a social and cultural phenomenon as much as an economic one.

AI on the Brain
A new study predicts a "likely decrease in learning skills, as LLMs reduce the cognitive effort required for writing," translating to poorer long-term knowledge retention.

Escape From New York
With Mamdani rising in New York, Texas can now offer New York’s leading businesses a package deal: relocate to Texas and list on the TXSE. Call it the Texas Two-Step.